Enteric pathogenic bacteria

Enteric pathogenic bacteria represent a broad category of microorganisms, including genera such as Salmonella, Shigella, and Campylobacter, that cause gastrointestinal infections (CDC, 2023). These pathogens typically invade the host via the fecal-oral route, leading to symptoms ranging from mild diarrhea to life-threatening systemic disease like typhoid fever (WHO, 2022). Their biological function involves the secretion of enterotoxins and the use of specialized secretion systems to manipulate host cell signaling and facilitate colonization (StatPearls, 2023). Therapeutic intervention primarily relies on antibiotics, which target bacterial-specific processes like cell wall synthesis or DNA gyrase activity (PubMed, 2021). However, the clinical management of these infections is increasingly challenged by the emergence of multi-drug resistant strains and the risk of disrupting the protective commensal gut microbiome (NIH, 2023). Furthermore, the use of certain antibiotics can trigger the release of Shiga toxins in specific strains, complicating treatment strategies (PubMed, 2020). Development of vaccines and narrow-spectrum antimicrobials remains a high priority to mitigate the global burden of enteric diseases (WHO, 2022).

Other names

Enteric pathogensGastrointestinal pathogensEnteropathogensGut pathogens

Antibiotics targeting these bacteria function through various mechanisms, including the inhibition of cell wall synthesis (e.g., beta-lactams), inhibition of protein synthesis (e.g., macrolides), or inhibition of DNA replication (e.g., fluoroquinolones) (StatPearls, 2023).